ELV
Elevance Health, Inc.
NYSE · usd
Elevance Health, Inc. (ELV) trades at $445.28 (+0.00%) as of 9:14:21 AM EDT on Oct 23, 2026, +11.72% over the past month. Market cap is $96.57B, with 3.9 days to cover in short interest.
Stock performance
How Elevance Health, Inc. (ELV) stock has performed from one day to one year, with its 52-week range.
- 1D
- +2.57%
- 1W
- +3.93%
- 1M
- +11.72%
- YTD
- +27.02%
- 1Y
- +30.07%
- 52-wk range
- $274.84 – $450.69
Key statistics
Today's trading snapshot for ELV: day range, open, previous close, volume and market cap.
- Day range
- $431.20 – $449.95
- Open
- $432.56
- Prev close
- $445.28
- Volume
- 1.43M
- Market cap
- $96.57B
- Shares out
- 216.87M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Elevance Health, Inc.: P/E, P/S, P/B, ROE and more.
- P/E
- 18.79
- P/S
- 0.48
- P/B
- 2.16
- P/FCF
- 14.82
- ROE
- 11.5%
- ROA
- 4.0%
- Debt/Equity
- 0.69
- Div yield
- 1.55%
As of Oct 22, 2026
8-K filings
Material corporate events Elevance Health, Inc. has disclosed to the SEC on Form 8-K.
- Earnings and performanceOct 21, 2026
On October 21, 2026, Elevance Health, Inc. issued a press release reporting its financial results for the quarter ended September 30, 2026.
- Guidance and outlookSep 10, 2026
During these meetings, Company officers will also reaffirm full year 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
- Guidance and outlookJun 10, 2026
Company officers will reaffirm the Company's shareholders' earnings guidance for full year 2026 to be at least $19.85 per diluted share, including approximately $6.90 per diluted share of net unfavorable items. Excluding these items, the Company continues to expect adjusted shareholders' earnings to be at least $26.75 per diluted share.
- Shareholder meetingsMay 13, 2026
On May 13, 2026, Elevance Health, Inc. (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting"). There were 194,441,339 shares of common stock represented at the Annual Meeting, constituting a quorum. The shareholders of the Company voted as follows on the matters set forth below: 1.Election of Directors. The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2029 based on the following votes: [detailed voting results for Gail K. Boudreaux, Robert L. Dixon, Jr., and Deanna D. Strable]
- Legal proceedingsMar 10, 2026
The Company was notified by the Centers for Medicare & Medicaid Services ('CMS') on February 27, 2026 of its intent to impose intermediate sanctions suspending enrollment of Medicare beneficiaries into the Company's Medicare Advantage-Prescription Drug plans and suspending certain communication activities to Medicare beneficiaries effective as of March 31, 2026 (the 'Sanctions'), unless CMS determines the issues identified have been satisfactorily addressed.
Dividend history and stock splits
Elevance Health, Inc.'s recent dividend payments and stock splits.
Dividends
- $1.72ex-div Dec 4, 2026
- $1.72ex-div Sep 10, 2026
- $1.72ex-div Jun 10, 2026
- $1.72ex-div Mar 10, 2026
Splits
- 2-for-1Jun 1, 2005
ELV short interest
How heavily ELV is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 3.9
- Short interest
- 4.85M
- Avg volume
- 1.24M
As of · reported to FINRA twice monthly.
ELV news
The latest news and headlines about Elevance Health, Inc. (ELV).
- Elevance: 3 Key Takeaways for Long-Term InvestorspositiveThe Motley Fool· Oct 21, 2026
- Elevance Health, Inc. (ELV) Hits Fresh High: Is There Still Room to Run?positiveZacks Investment Research· Oct 21, 2026
- ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 OutlookpositiveZacks Investment Research· Oct 21, 2026
- Humana Gains From Premium Growth Despite Rising Benefit CostspositiveZacks Investment Research· Oct 21, 2026
- Elevance Health (ELV) Surpasses Q3 Earnings and Revenue EstimatespositiveZacks Investment Research· Oct 21, 2026
Frequently asked questions
What is the Elevance Health, Inc. (ELV) stock price today?
Elevance Health, Inc. (ELV) is trading at $445.28 (+0.00% on the day) as of 9:14:21 AM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Elevance Health, Inc.?
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans.
What is the short interest in ELV?
As of Sep 30, 2026, ELV has 4.85M shares short and 3.9 days to cover.
Does Elevance Health, Inc. (ELV) pay a dividend?
Yes. Elevance Health, Inc. (ELV)'s most recent dividend was $1.72 per share, with an ex-dividend date of Dec 4, 2026. Full ELV dividend history is available from the Massive API.
What exchange is ELV listed on?
Elevance Health, Inc. (ELV) trades on NYSE in USD, in the HOSPITAL & MEDICAL SERVICE PLANS industry.
Build with AI
Build an analysis of ELV with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ELV analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.